CYP2C19 and diabetes mellitus: Table 4 shows the use and prevalence of use of the most frequently prescribed PGx drugs having AGs or N-AGs for CYP2D6, CYP2C19 and SLCO1B1 in the general population and among persons with diabetes (A10) sorted by ATC codes.